July 2, 20240CommentsA Zombie Stock Gets a LifelineWhile we believe the risk of this stock going to $0/share is diminished, the stock remains significantly overvalued. by Kyle Guske II, Senior Investment Analyst, MBA
July 1, 20240CommentsRacing to ZeroEven after falling year-to-date, this stock has an unwarranted $9 billion market cap and could fall much further. by Kyle Guske II, Senior Investment Analyst, MBA
June 3, 20240CommentsNot So BrightWe believe that this company cannot meet the future cash flow expectations baked into its current stock price and holds further downside risk. by Kyle Guske II, Senior Investment Analyst, MBA
May 31, 20240CommentsICYMI: New AI Partnership, New E-Letter From David Trainer, New Featured Stock, & Model Portfolio UpdatesHere's what happened at New Constructs this past week. by Kyle Guske II, Senior Investment Analyst, MBA
May 28, 20240CommentsPerfect Example of Wall Street Robbery By a Zombie StockWhat would you think if I told you the CEO of a business that had to secure a $1 billion loan to stave off bankruptcy got paid over $100 million dollars? by David Trainer, Founder & CEO
May 20, 20240Comments“It is the sovereign privilege of a free citizen”The meme stock frenzy highlights the lack of reliable fundamental research, which creates a vacuum for mis-information. by David Trainer, Founder & CEO
May 15, 20240CommentsStocks I Would Trust With My Family’s MoneyLearn about the number one “clue” we look for in the fine print to know if we can trust a company and its management. by Kyle Guske II, Senior Investment Analyst, MBA
May 13, 20242CommentsThis Door May Be Closing SoonWe want to remind investors that the disconnect between this company's fundamentals and the stock’s valuation remains ridiculous. by Kyle Guske II, Senior Investment Analyst, MBA
May 3, 20240CommentsICYMI: New Long Idea, Reports on the Worst Sector & Style ETFs & Mutual Funds 2Q24, & Model Portfolio UpdatesHere's what happened at New Constructs this past week. by Kyle Guske II, Senior Investment Analyst, MBA
April 22, 20240CommentsPodcast: Why This Zombie Insurance Stock is Back in the Danger ZoneCEO David Trainer sat down with Chuck Jaffe of Money Life to talk about our Danger Zone pick this week: Trupanion (TRUP). by Kyle Guske II, Senior Investment Analyst, MBA
April 19, 20240CommentsICYMI: New Long Idea, New E-Letter from David Trainer, 2Q24 Style Ratings & Model Portfolio UpdatesHere's what happened at New Constructs this past week. by Kyle Guske II, Senior Investment Analyst, MBA
April 15, 20240CommentsDon’t Believe the HypeI think you’d be hard pressed to find a single investor who thinks the market is undervalued. by David Trainer, Founder & CEO
April 9, 20240CommentsMeet the New Boss, Same as the Old BossDo you ever get the feeling that a decision you’re making in the moment might change your life forever? by David Trainer, Founder & CEO
April 8, 20240CommentsUnfiltered RiskWe do not think the company’s fundamentals can justify the expectations baked into its current stock price. by Kyle Guske II, Senior Investment Analyst, MBA
April 1, 20240CommentsAll Bark, No BiteWe believe this company will not come close to meeting the future cash flow expectations baked into its current stock price. by Kyle Guske II, Senior Investment Analyst, MBA
March 29, 20240CommentsICYMI: New Long Idea, Filing Season 2024 Recap, Special Offer: Value Investing Accelerator Training Program, & Model Portfolio UpdatesHere's what happened at New Constructs this past week. by Kyle Guske II, Senior Investment Analyst, MBA
March 22, 20240CommentsICYMI: New Long Idea, Danger Zone Update, Hidden Gems From the Footnotes, The Value Investing Accelerator Training Program, & Model Portfolio UpdatesHere's what happened at New Constructs this past week. by Kyle Guske II, Senior Investment Analyst, MBA
March 18, 20240CommentsBitter TasteWith the stock up over 90% YTD, we want to remind investors just how large the disconnect between company fundamentals and stock valuation remains. by Hakan Salt, Associate Investment Analyst
March 18, 20240CommentsPodcast: Why this Fast Casual Zombie Stock is Back in the Danger ZoneSenior Investment Analyst Kyle Guske II sat down with Chuck Jaffe of Money Life to talk about our Danger Zone pick this week: Bitter Taste. by Kyle Guske II, Senior Investment Analyst, MBA
March 15, 20240CommentsICYMI: New Secret Metric Webinar Signup, Long Idea Update, An Automaker All Out of Gas, Key Filing Season Finds, The Value Investing Accelerator, & Model Portfolio UpdatesHere's what happened at New Constructs this past week. by Kyle Guske II, Senior Investment Analyst, MBA